Stoke Therapeutics, Inc. (STOK) has a consensus analyst rating of Buy, based on 15 analysts covering the stock. Of those, 12 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for STOK is $42.75, representing a +19.2% upside from the current price of $35.86. Price targets range from a low of $35.00 to a high of $60.00.
